Advent Life Sciences Fund II LP
Advent Life Sciences · adviser of record: Advent Life Sciences LLP · 2014 vintage
Advent Life Sciences Fund II LP is a 2014 venture fund managed by Advent Life Sciences, with $226mm raised (Form D, amount sold). It reported $159mm in gross assets at year-end 2025, 0.70x its size, against a peak of $210mm in 2019.
- Latest value held
- $159mm year-end 2025
- Peak
- $210mm year-end 2019
- Fund size
- $226mm Form D, amount sold
- Held vs. size
- 0.70x peak 0.93x
Value held by year-end
Gross asset value reported on Form ADV at each year-end. Dashed line: fund size. Open in the Fund Tracker
| Year-end | Gross assets | ÷ size | Change |
|---|---|---|---|
| 2025 | $159mm | 0.70x | -4% over 2 yrs |
| 2023 | $166mm | 0.73x | -13% |
| 2022 | $190mm | 0.84x | -2% |
| 2021 | $193mm | 0.85x | -8% |
| 2020 | $210mm | 0.93x | -0% |
| 2019 | $210mm | 0.93x | +10% |
| 2018 | $192mm | 0.85x | +1% |
| 2017 | $190mm | 0.84x | +10% |
| 2016 | $173mm | 0.76x | -16% |
| 2015 | $205mm | 0.91x | -2% |
| 2014 | $210mm | 0.93x | – |
Other funds from Advent Life Sciences
- Advent-Harrington Impact Fund LP 2020
- Advent Life Sciences II CO-Invest LP 2019
- Advent Life Sciences Fund III LP 2018
- Advent Life Sciences Fund I LP 2014
- Biomotiv LLC 2012
All Advent Life Sciences funds
About these numbers
Gross asset value is what the manager reports holding in the fund at each fiscal year-end, on SEC Form ADV, Schedule D. It includes the GP’s own commitment and is before carried interest, so it is not the LPs’ net return, and it does not show cash already distributed. A fall in value can mean distributions, markdowns or both. Fund size is the amount sold reported on Form D, which for some funds reflects only a first close. Private fund ID 805-3053351816. Data updated October 13, 2026.
Is this your fund?
Spot an error and email a correction. Facing DPI pressure? See how distribution financing works.